High cost factors for leukaemia and lymphoma patients: A new analysis of costs within these diagnosis related groups

Journal of Epidemiology and Community Health

Volumn 53, Issue 1, 1999, Pages 24-31

  Quantin, Catherine ^a,c   Entezam, Farhad ^a   Brunet Lecomte, Patrick ^a   Lepage, Eric ^b   Guy, Henri ^a   Dusserre, Liliane ^a  

^a DIJON UNIVERSITY HOSPITAL   (France)

^b HENRI MONDOR HOSPITAL   (France)

^c HÔPITAL DU BOCAGE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD TRANSFUSION; CANCER CHEMOTHERAPY; CANCER MORTALITY; CENTRAL VENOUS CATHETERIZATION; DRUG COST; FRANCE; HEALTH CARE COST; HOSPITALIZATION; HUMAN; LAMINAR AIRFLOW; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; NEUTROPENIA; PARENTERAL NUTRITION; REGRESSION ANALYSIS; SEPTICEMIA;

EID: 0032895781     PISSN: 0143005X     EISSN: None     Source Type: Journal    
DOI: 10.1136/jech.53.1.24     Document Type: Article

References (26)

1. Fetter RB, Youngsoo S, Freeman JL, et al. Case-mix; definition by diagnosis related groups. Med Care 1980;18 (suppl 2):1-53.
2. De Pouvourville G, Comar L, Bouvier V. Le paiement à la pathologie des hôpitaux : l'expérience française. Rev Epidemiol Sante Publique 1994;42:68-78.
3. Gonella JS, Hornbrook MC, Louis DZ. Staging of disease: a case-mix group measurement. Journal of American Statistical Association 1984;263:241-6.
4. Young W, Swinkola R, Hutton M. Assessment of the AUTOGRP patient Classification System. Med Care 1980; 18:228-44.
5. Froelich H, Jarvis WR. Economic impact of diagnosis-related groups and severity of illness on reimbursement for central nervous system infections. J Pediatr 1991;118:693-7.
6. Kelleher C. Relationship of physician ratings of severity of illness and difficulty of clinical management of stay. Health Sen Res 1993;27:841-55.
7. Naessens JM, Leibsom CL, Iqbal Krishan MD. Contribution of a measure of disease complexity (Complex) to prediction of outcome and charges among hospitalised patients. Mayo Clin Proc 1992;67:1140-9.
8. Dayhoff DA, Cromwell J. Measuring differences and similarities in hospital caseloads: a conceptual and empirical analysis. Health Serv Res 1993;28:293-312.
9. Averill RF, Mc Guire TE, Manning BE, et al. A study of relationship between severity of illness and hospital cost in New Jersey hospitals. Health Serv Res 1992;27:587-606.
10. Horn SD, Horn RA, Sharkey PD, et al. Severity of illness within DRGs: homogeneity study. Med Care 1986;24:225-35.
11. Horn SD, Sharkey PD, Chambers AF, et al. Severity of illness within DRGs: impact on propective payment. Am J Public Health 1985;75:1195-9.
12. Thomas JW, Aschcraft MLF. Measuring severity of illness: six severity systems and their ability to explain cost variations. Inquiry 1991;28:39-55.
13. Horn SD, Sharkey PD, Buckle JM, et al. The relationship between sverity of illness and hospital length of stay and mortality. Med Care 1991;29:305-17.
14. Knaus WA, Draper EA, Wagner DP, et al. APACHE II: A severity of disease classification system. Crit Care Med 1985;13:818-29.
15. Iezzoni LJ, Ash AS, Coffman GA, et al. Admission and midstay MedisGroups scores as predictors of hospitalization charges. Med Care 1991;29:210-20.
16. Galore KA, Iezzoni L. Disease staging and PMCs: Can they improve DRGs ? Med Care 1987;8:724-37.
17. Voss G, Hasman A, Rutten F, et al. Explaining cost variations in DRGs "acute myocardial infarction" by severity of illness. Health Policy 1994;28:37-50.
18. Freeman JL, Fetter RB, Schneider KC, et al. Diagnosis-related group refinement with diagnosis- and procedure-specific comorbidities and complications. Med Care;33:806-27.
19. Bennett JM, Catovsky D, Daniel MT, et al. Proposed revised criteria for the classification of acute myeloid leukaemia. A report of the French-American-British Co-operative Group. Ann Intern Med 1985;103:620-5.
20. Quantin C, Entezam F, Bourdais C, et al. Modelization of long-stay and high cost patient distribution within bronchopneumopathies and leukemia or lymphoma diagnosis related groups. Rev Epidermal Same Publique 1997;45:117-30.
21. Kotagal UR, Perlstein PH, Atherton HD, et al. Acuity scores as predictors of cost-related outcomes of neonatal intensive care. J Pediatr 1993;123:355-64.
22. Rosina F, Alaria P, Castelli S, et al. Effect of patient characteristics on hospital costs for cirrhosis : implications for the disease-related group (DRG) reimbursement system. Ital J Gastroenterol 1996;28:401-5.
23. Clayton MC, Solem LD, Ahrenholz DH. Pulmonry failure in geriatric patients with burns: the need for a diagnosis-related group modifier. J Burn Care Rehabil 1995;16:451-4.
24. Hendrie D, Rosman DL, Harris AH. Hospital impatient costs resulting from road crashes in Western Australia. Aust J Public Health 1994;18:380-8.
25. Shwartz M, Iezzoni LI, Ash AS, et al. Do severity measures explain differences in length of hospital stay ? The case of hip fracture. Health Serv Res 1996;31:365-85.
26. Sappington D. Incentives in principal-agent relationships. Journal of Economic Perspective 1991;5:45.